Effectiveness of Shared Decision-making for Diabetes Prevention: 12-Month Results from the Prediabetes Informed Decision and Education (PRIDE) Trial

摘要

ImportanceIntensive lifestyle change (e.g., the Diabetes Prevention Program) and metformin reduce type 2 diabetes risk among patients with prediabetes. However, real-world uptake remains low. Shared decision-making (SDM) may increase awareness and help patients select and follow through with informed options for diabetes prevention that are aligned with their preferences.ObjectiveTo test the effectiveness of a prediabetes SDM intervention.DesignCluster randomized controlled trial.SettingTwenty primary care clinics within a large regional health system.ParticipantsOverweight/obese adults with prediabetes (BMI >= 24 kg/m(2) and HbA1c 5.7-6.4%) were enrolled from 10 SDM intervention clinics. Propensity score matching was used to identify control patients from 10 usual care clinics.InterventionIntervention clinic patients were invited to participate in a face-to-face SDM visit with a pharmacist who used a decision aid (DA) to describe prediabetes and four possible options for diabetes prevention: DPP, DPP metformin, metformin only, or usual care.Main Outcomes and MeasuresPrimary endpoint was uptake of DPP (>= 9 sessions), metformin, or both strategies at 4 months. Secondary endpoint was weight change (lbs.) at 12 months.ResultsUptake of DPP and/or metformin was higher among SDM participants (n =351) than controls receiving usual care (n =1028; 38% vs. 2%, p <.001). At 12-month follow-up, adjusted weight loss (lbs.) was greater among SDM participants than controls (-5.3 vs. -0.2, p<.001).LimitationsAbsence of DPP supplier participation data for matched patients in usual care clinics.Conclusions and RelevanceA prediabetes SDM intervention led by pharmacists increased patient engagement in evidence-based options for diabetes prevention and was associated with significantly greater uptake of DPP and/or metformin at 4 months and weight loss at 12 months. Prediabetes SDM may be a promising approach to enhance prevention efforts among patients at increased risk.Trial Registration p id=ParThis study was registered at clinicaltrails.gov (NCT02384109)).